Skip to main content
. 2020 Oct 17;21(4):423–434. doi: 10.1038/s41397-020-00195-4

Fig. 4. Analysis of the reference drug labels (refDLs).

Fig. 4

Number of reference drug labels per PGx level (A, B), per anatomic group and the assigned PGx levels (C), and per biomarker (D, E).